In DepthPUBLIC HEALTH

Gates and NIH join forces on HIV and sickle cell diseases

See allHide authors and affiliations

Science  01 Nov 2019:
Vol. 366, Issue 6465, pp. 558-559
DOI: 10.1126/science.366.6465.558-b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

An unusual collaboration between the U.S. National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation aims to take on the breathtakingly complex challenge of bringing cutting-edge, gene-based cures for HIV and sickle cell disease to sub-Saharan Africa. Each partner will devote at least $100 million over the next 4 years to speeding the development of interventions that are already showing promise in clinical trials but will need to be retooled to be feasible in a region that still struggles to have access to basic medicines. The goal is to steer clear of expensive, complex strategies that require stem cell transplantation.

View Full Text